Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2025 08:00 ET | Source: Qu Biologics, Inc.

Qu Biologics’ Immunomodulator Improves Fatty Liver Disease

BURNABY, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation...
March 14, 2024 17:18 ET | Source: Global Liver Institute

FDA’s Approval of Breakthrough NASH Treatment Opens Door for a Long-Neglected Patient Population

Washington, DC, March 14, 2024 (GLOBE NEWSWIRE) -- Today, Global Liver Institute (GLI) recognizes the importance of the first approval by the U.S. Food and Drug Administration (FDA) of a medication...